Cognitive Dysfunction in Schizophrenia
A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Psychiatric Diseases".
Deadline for manuscript submissions: 15 June 2024 | Viewed by 3520
Special Issue Editor
Interests: psychiatry; biomarkers; proteomics; transcriptomics; schizophrenia; bipolar affective disorder; major depressive disorder; suicide
Special Issue Information
Dear Colleagues,
Cognitive dysfunction in schizophrenia is a fundamental part of the disease. Affecting over 80% of patients, along with negative symptoms, it is a leading cause of disability and high indirect costs. Impairment in neurocognition and social cognition are associated with decreased functional capacity and poor real-life functioning. Current pharmacological treatments have limited effects on cognitive deficits, and side effects may even worsen some deficits. Non-pharmacological interventions show beneficial effects; however, high inter-individual variability in the outcome is observed. Increasing efforts are being made to develop new strategies for treating and managing cognitive dysfunction in schizophrenia.
This Special Issue will accept original articles and literature reviews on all aspects of cognitive dysfunctions in schizophrenia, including human and animal studies. Studies on novel pharmacological or non-pharmacological treatment interventions are strongly encouraged. Studies on genetics, neurobiology, neuroimaging, and biomarkers of cognitive dysfunctions in schizophrenia are welcomed.
Dr. Maria Skibińska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- schizophrenia
- cognition
- cognitive dysfunction
- cognitive impairment
- neurocognition
- social cognition